Register Login
Register to leave comments
  • News bot April 2, 2026, 11:41 a.m.

    📋 CONTEXT THERAPEUTICS INC. (CNTX) - Clinical Trial Update

    Filing Date: 2026-04-02

    Accepted: 2026-04-02 07:41:09

    Event Type: Clinical Trial Update

    Event Details:

    CONTEXT THERAPEUTICS INC. (CNTX) Announces Clinical Trial Update CONTEXT THERAPEUTICS INC. (CNTX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: expected, Designation
    • Diseases/Conditions: solid tumors, CTIM-76
    • Clinical Stage: Phase 1, clinical trial
    • Collaboration: PROCCTIM-76 Phase 1a
      • expected in June 2026

    🔬 Clinical Development Pipeline (CONTEXT THERAPEUTICS INC.):

    Product Type Development Stage Therapeutic Area Source
    CTIM-76 DRUG Phase PHASE1 Platinum-resistant Ovarian Cancer ClinicalTrials.gov
    CT-95 DRUG Phase PHASE1 Mesothelin-Expressing Tumors ClinicalTrials.gov
    Palbociclib DRUG Phase PHASE1 Metastatic Breast Cancer ClinicalTrials.gov
    Letrozole DRUG Phase PHASE1 Metastatic Breast Cancer ClinicalTrials.gov
    Fulvestrant DRUG Phase PHASE2 ER-positive Breast Cancer ClinicalTrials.gov
    Onapristone ER + Anastrozole DRUG Phase PHASE2 Granulosa Cell Ovarian Cancer ClinicalTrials.gov
    Onapristone ER DRUG Phase PHASE1 Metastatic Breast Cancer ClinicalTrials.gov
    Onapristone DRUG Phase PHASE2 ER-positive Breast Cancer ClinicalTrials.gov
    Elacestrant DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov
    Questionnaire Administration OTHER Phase PHASE2 Refractory Endometrial Adenocarcinoma ClinicalTrials.gov
    Quality-of-Life Assessment OTHER Phase PHASE2 Refractory Endometrial Adenocarcinoma ClinicalTrials.gov
    Anastrozole DRUG Phase PHASE2 Refractory Endometrial Adenocarcinoma ClinicalTrials.gov
    Extended-release Onapristone DRUG Phase PHASE2 Refractory Endometrial Adenocarcinoma ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: CONTEXT THERAPEUTICS INC.
    • Ticker Symbol: CNTX

Search

News categories